home > ict > winter 2020 > keeping trials connected
International Clinical Trials

Keeping Trials Connected

Staying up to date with the latest advances in cellular technologies is exhausting at best. Sometimes, just keeping the acronyms straight can be too much to handle (see NBIoT, Cat-M1, and EC-GSM-IoT), let alone adding in the complications that come with supporting an international clinical trial deployment. If you haven’t yet experienced these dynamics, just sit down with someone in your technical operations group and ask why device certification and cellular band support matter when it comes to clinical trials in Japan.

While it’s true that connected clinical trials have moved from being a value differentiator to simply becoming an industry standard, it is estimated that most people live more than two hours away from a clinical study site. Connectivity dramatically shortens that distance, virtually. The ability to retain clinical trial participants increases dramatically with less reliance upon the study site.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

About the author

Stephen Byrne currently serves as the EU Managing Director of KORE. With more than 20 years of experience in healthcare and medical device technology implementation, he brings a wealth of information relating to the complexities associated with European and global clinical trial deployments.
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals renews its “Credit Impôt Recherche” (CIR) by the French Ministry of Higher Education and Research

[Noáin, April 22, 2020] 3P Biopharmaceuticals, a European leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has successfully extended its French CIR certificate for another four-year period: 2020-2024.
More info >>

White Papers

Nasal Drug Delivery with a Focus on Chronic Rhino-Sinusitis

Aptar Pharma

Aptar Pharma have hosted a scientific roundtable on “Nasal drug delivery with a focus on chronic rhino‑sinusitis”. This international scientific forum was held in Paris, France on November 13th 2012. The roundtable was organized to explore and exchange views on the science of various forms of sinusitis and its related unmet medical needs.
More info >>

Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement